Chapter/Section Purchase

1 Study Coverage
1.1 Fibroblast Growth Factor Receptor 4 Product Introduction
1.2 Market by Type
1.2.1 Global Fibroblast Growth Factor Receptor 4 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 BLU-9931
1.2.3 BMS-986036
1.2.4 Erdafitinib
1.2.5 ES-135
1.2.6 FGF-401
1.2.7 Others
1.3 Market by Application
1.3.1 Global Fibroblast Growth Factor Receptor 4 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.3.4 Melanoma
1.3.5 Fallopian Tube Cancer
1.3.6 Lung Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Fibroblast Growth Factor Receptor 4 Sales Estimates and Forecasts 2017-2028
2.2 Global Fibroblast Growth Factor Receptor 4 Revenue Estimates and Forecasts 2017-2028
2.3 Global Fibroblast Growth Factor Receptor 4 Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Fibroblast Growth Factor Receptor 4 Sales by Region
2.4.1 Global Fibroblast Growth Factor Receptor 4 Sales by Region (2017-2022)
2.4.2 Global Sales Fibroblast Growth Factor Receptor 4 by Region (2023-2028)
2.5 Global Fibroblast Growth Factor Receptor 4 Revenue by Region
2.5.1 Global Fibroblast Growth Factor Receptor 4 Revenue by Region (2017-2022)
2.5.2 Global Fibroblast Growth Factor Receptor 4 Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Fibroblast Growth Factor Receptor 4 Sales by Manufacturers
3.1.1 Global Top Fibroblast Growth Factor Receptor 4 Manufacturers by Sales (2017-2022)
3.1.2 Global Fibroblast Growth Factor Receptor 4 Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Fibroblast Growth Factor Receptor 4 in 2021
3.2 Global Fibroblast Growth Factor Receptor 4 Revenue by Manufacturers
3.2.1 Global Fibroblast Growth Factor Receptor 4 Revenue by Manufacturers (2017-2022)
3.2.2 Global Fibroblast Growth Factor Receptor 4 Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Fibroblast Growth Factor Receptor 4 Revenue in 2021
3.3 Global Fibroblast Growth Factor Receptor 4 Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Fibroblast Growth Factor Receptor 4 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Fibroblast Growth Factor Receptor 4 Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Fibroblast Growth Factor Receptor 4 Sales by Type
4.1.1 Global Fibroblast Growth Factor Receptor 4 Historical Sales by Type (2017-2022)
4.1.2 Global Fibroblast Growth Factor Receptor 4 Forecasted Sales by Type (2023-2028)
4.1.3 Global Fibroblast Growth Factor Receptor 4 Sales Market Share by Type (2017-2028)
4.2 Global Fibroblast Growth Factor Receptor 4 Revenue by Type
4.2.1 Global Fibroblast Growth Factor Receptor 4 Historical Revenue by Type (2017-2022)
4.2.2 Global Fibroblast Growth Factor Receptor 4 Forecasted Revenue by Type (2023-2028)
4.2.3 Global Fibroblast Growth Factor Receptor 4 Revenue Market Share by Type (2017-2028)
4.3 Global Fibroblast Growth Factor Receptor 4 Price by Type
4.3.1 Global Fibroblast Growth Factor Receptor 4 Price by Type (2017-2022)
4.3.2 Global Fibroblast Growth Factor Receptor 4 Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Fibroblast Growth Factor Receptor 4 Sales by Application
5.1.1 Global Fibroblast Growth Factor Receptor 4 Historical Sales by Application (2017-2022)
5.1.2 Global Fibroblast Growth Factor Receptor 4 Forecasted Sales by Application (2023-2028)
5.1.3 Global Fibroblast Growth Factor Receptor 4 Sales Market Share by Application (2017-2028)
5.2 Global Fibroblast Growth Factor Receptor 4 Revenue by Application
5.2.1 Global Fibroblast Growth Factor Receptor 4 Historical Revenue by Application (2017-2022)
5.2.2 Global Fibroblast Growth Factor Receptor 4 Forecasted Revenue by Application (2023-2028)
5.2.3 Global Fibroblast Growth Factor Receptor 4 Revenue Market Share by Application (2017-2028)
5.3 Global Fibroblast Growth Factor Receptor 4 Price by Application
5.3.1 Global Fibroblast Growth Factor Receptor 4 Price by Application (2017-2022)
5.3.2 Global Fibroblast Growth Factor Receptor 4 Price Forecast by Application (2023-2028)
6 North America
6.1 North America Fibroblast Growth Factor Receptor 4 Market Size by Type
6.1.1 North America Fibroblast Growth Factor Receptor 4 Sales by Type (2017-2028)
6.1.2 North America Fibroblast Growth Factor Receptor 4 Revenue by Type (2017-2028)
6.2 North America Fibroblast Growth Factor Receptor 4 Market Size by Application
6.2.1 North America Fibroblast Growth Factor Receptor 4 Sales by Application (2017-2028)
6.2.2 North America Fibroblast Growth Factor Receptor 4 Revenue by Application (2017-2028)
6.3 North America Fibroblast Growth Factor Receptor 4 Market Size by Country
6.3.1 North America Fibroblast Growth Factor Receptor 4 Sales by Country (2017-2028)
6.3.2 North America Fibroblast Growth Factor Receptor 4 Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Fibroblast Growth Factor Receptor 4 Market Size by Type
7.1.1 Europe Fibroblast Growth Factor Receptor 4 Sales by Type (2017-2028)
7.1.2 Europe Fibroblast Growth Factor Receptor 4 Revenue by Type (2017-2028)
7.2 Europe Fibroblast Growth Factor Receptor 4 Market Size by Application
7.2.1 Europe Fibroblast Growth Factor Receptor 4 Sales by Application (2017-2028)
7.2.2 Europe Fibroblast Growth Factor Receptor 4 Revenue by Application (2017-2028)
7.3 Europe Fibroblast Growth Factor Receptor 4 Market Size by Country
7.3.1 Europe Fibroblast Growth Factor Receptor 4 Sales by Country (2017-2028)
7.3.2 Europe Fibroblast Growth Factor Receptor 4 Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Fibroblast Growth Factor Receptor 4 Market Size by Type
8.1.1 Asia Pacific Fibroblast Growth Factor Receptor 4 Sales by Type (2017-2028)
8.1.2 Asia Pacific Fibroblast Growth Factor Receptor 4 Revenue by Type (2017-2028)
8.2 Asia Pacific Fibroblast Growth Factor Receptor 4 Market Size by Application
8.2.1 Asia Pacific Fibroblast Growth Factor Receptor 4 Sales by Application (2017-2028)
8.2.2 Asia Pacific Fibroblast Growth Factor Receptor 4 Revenue by Application (2017-2028)
8.3 Asia Pacific Fibroblast Growth Factor Receptor 4 Market Size by Region
8.3.1 Asia Pacific Fibroblast Growth Factor Receptor 4 Sales by Region (2017-2028)
8.3.2 Asia Pacific Fibroblast Growth Factor Receptor 4 Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Fibroblast Growth Factor Receptor 4 Market Size by Type
9.1.1 Latin America Fibroblast Growth Factor Receptor 4 Sales by Type (2017-2028)
9.1.2 Latin America Fibroblast Growth Factor Receptor 4 Revenue by Type (2017-2028)
9.2 Latin America Fibroblast Growth Factor Receptor 4 Market Size by Application
9.2.1 Latin America Fibroblast Growth Factor Receptor 4 Sales by Application (2017-2028)
9.2.2 Latin America Fibroblast Growth Factor Receptor 4 Revenue by Application (2017-2028)
9.3 Latin America Fibroblast Growth Factor Receptor 4 Market Size by Country
9.3.1 Latin America Fibroblast Growth Factor Receptor 4 Sales by Country (2017-2028)
9.3.2 Latin America Fibroblast Growth Factor Receptor 4 Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Fibroblast Growth Factor Receptor 4 Market Size by Type
10.1.1 Middle East and Africa Fibroblast Growth Factor Receptor 4 Sales by Type (2017-2028)
10.1.2 Middle East and Africa Fibroblast Growth Factor Receptor 4 Revenue by Type (2017-2028)
10.2 Middle East and Africa Fibroblast Growth Factor Receptor 4 Market Size by Application
10.2.1 Middle East and Africa Fibroblast Growth Factor Receptor 4 Sales by Application (2017-2028)
10.2.2 Middle East and Africa Fibroblast Growth Factor Receptor 4 Revenue by Application (2017-2028)
10.3 Middle East and Africa Fibroblast Growth Factor Receptor 4 Market Size by Country
10.3.1 Middle East and Africa Fibroblast Growth Factor Receptor 4 Sales by Country (2017-2028)
10.3.2 Middle East and Africa Fibroblast Growth Factor Receptor 4 Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Amgen Inc
11.1.1 Amgen Inc Corporation Information
11.1.2 Amgen Inc Overview
11.1.3 Amgen Inc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Amgen Inc Fibroblast Growth Factor Receptor 4 Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Amgen Inc Recent Developments
11.2 ArQule Inc
11.2.1 ArQule Inc Corporation Information
11.2.2 ArQule Inc Overview
11.2.3 ArQule Inc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 ArQule Inc Fibroblast Growth Factor Receptor 4 Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 ArQule Inc Recent Developments
11.3 AstraZeneca Plc
11.3.1 AstraZeneca Plc Corporation Information
11.3.2 AstraZeneca Plc Overview
11.3.3 AstraZeneca Plc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 AstraZeneca Plc Fibroblast Growth Factor Receptor 4 Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AstraZeneca Plc Recent Developments
11.4 Blueprint Medicines Corp
11.4.1 Blueprint Medicines Corp Corporation Information
11.4.2 Blueprint Medicines Corp Overview
11.4.3 Blueprint Medicines Corp Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Blueprint Medicines Corp Fibroblast Growth Factor Receptor 4 Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Blueprint Medicines Corp Recent Developments
11.5 Bristol-Myers Squibb Co
11.5.1 Bristol-Myers Squibb Co Corporation Information
11.5.2 Bristol-Myers Squibb Co Overview
11.5.3 Bristol-Myers Squibb Co Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Bristol-Myers Squibb Co Fibroblast Growth Factor Receptor 4 Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bristol-Myers Squibb Co Recent Developments
11.6 Eisai Co Ltd
11.6.1 Eisai Co Ltd Corporation Information
11.6.2 Eisai Co Ltd Overview
11.6.3 Eisai Co Ltd Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Eisai Co Ltd Fibroblast Growth Factor Receptor 4 Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Eisai Co Ltd Recent Developments
11.7 Eli Lilly and Co
11.7.1 Eli Lilly and Co Corporation Information
11.7.2 Eli Lilly and Co Overview
11.7.3 Eli Lilly and Co Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Eli Lilly and Co Fibroblast Growth Factor Receptor 4 Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Eli Lilly and Co Recent Developments
11.8 Genosco Inc
11.8.1 Genosco Inc Corporation Information
11.8.2 Genosco Inc Overview
11.8.3 Genosco Inc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Genosco Inc Fibroblast Growth Factor Receptor 4 Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Genosco Inc Recent Developments
11.9 H3 Biomedicine Inc
11.9.1 H3 Biomedicine Inc Corporation Information
11.9.2 H3 Biomedicine Inc Overview
11.9.3 H3 Biomedicine Inc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 H3 Biomedicine Inc Fibroblast Growth Factor Receptor 4 Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 H3 Biomedicine Inc Recent Developments
11.10 Incyte Corp
11.10.1 Incyte Corp Corporation Information
11.10.2 Incyte Corp Overview
11.10.3 Incyte Corp Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Incyte Corp Fibroblast Growth Factor Receptor 4 Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Incyte Corp Recent Developments
11.11 Ionis Pharmaceuticals Inc
11.11.1 Ionis Pharmaceuticals Inc Corporation Information
11.11.2 Ionis Pharmaceuticals Inc Overview
11.11.3 Ionis Pharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Ionis Pharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Ionis Pharmaceuticals Inc Recent Developments
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Corporation Information
11.12.2 Johnson & Johnson Overview
11.12.3 Johnson & Johnson Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Johnson & Johnson Fibroblast Growth Factor Receptor 4 Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Johnson & Johnson Recent Developments
11.13 Merrimack Pharmaceuticals Inc
11.13.1 Merrimack Pharmaceuticals Inc Corporation Information
11.13.2 Merrimack Pharmaceuticals Inc Overview
11.13.3 Merrimack Pharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Merrimack Pharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Merrimack Pharmaceuticals Inc Recent Developments
11.14 NGM Biopharmaceuticals Inc
11.14.1 NGM Biopharmaceuticals Inc Corporation Information
11.14.2 NGM Biopharmaceuticals Inc Overview
11.14.3 NGM Biopharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 NGM Biopharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 NGM Biopharmaceuticals Inc Recent Developments
11.15 Novartis AG
11.15.1 Novartis AG Corporation Information
11.15.2 Novartis AG Overview
11.15.3 Novartis AG Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Novartis AG Fibroblast Growth Factor Receptor 4 Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Novartis AG Recent Developments
11.16 Principia Biopharma Inc
11.16.1 Principia Biopharma Inc Corporation Information
11.16.2 Principia Biopharma Inc Overview
11.16.3 Principia Biopharma Inc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Principia Biopharma Inc Fibroblast Growth Factor Receptor 4 Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Principia Biopharma Inc Recent Developments
11.17 Tasly Pharmaceutical Group Co Ltd
11.17.1 Tasly Pharmaceutical Group Co Ltd Corporation Information
11.17.2 Tasly Pharmaceutical Group Co Ltd Overview
11.17.3 Tasly Pharmaceutical Group Co Ltd Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Tasly Pharmaceutical Group Co Ltd Fibroblast Growth Factor Receptor 4 Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Tasly Pharmaceutical Group Co Ltd Recent Developments
11.18 Vichem Chemie Research Ltd
11.18.1 Vichem Chemie Research Ltd Corporation Information
11.18.2 Vichem Chemie Research Ltd Overview
11.18.3 Vichem Chemie Research Ltd Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Vichem Chemie Research Ltd Fibroblast Growth Factor Receptor 4 Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Vichem Chemie Research Ltd Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Fibroblast Growth Factor Receptor 4 Industry Chain Analysis
12.2 Fibroblast Growth Factor Receptor 4 Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Fibroblast Growth Factor Receptor 4 Production Mode & Process
12.4 Fibroblast Growth Factor Receptor 4 Sales and Marketing
12.4.1 Fibroblast Growth Factor Receptor 4 Sales Channels
12.4.2 Fibroblast Growth Factor Receptor 4 Distributors
12.5 Fibroblast Growth Factor Receptor 4 Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Fibroblast Growth Factor Receptor 4 Industry Trends
13.2 Fibroblast Growth Factor Receptor 4 Market Drivers
13.3 Fibroblast Growth Factor Receptor 4 Market Challenges
13.4 Fibroblast Growth Factor Receptor 4 Market Restraints
14 Key Findings in The Global Fibroblast Growth Factor Receptor 4 Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer